BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36262092)

  • 21. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study.
    Wu SY; Li JW; Wang YJ; Jin KR; Yang BL; Li JJ; Yu XL; Mo M; Hu N; Shao ZM; Liu GY
    Int J Surg; 2023 Jul; 109(7):1863-1870. PubMed ID: 37132193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
    Nijveldt JJ; Rajan KK; Boersma K; Noorda EM; van der Starre-Gaal J; Kate MV'V; Roeloffzen EMA; Vendel BN; Beek MA; Francken AB
    Ann Surg Oncol; 2024 Jul; 31(7):4477-4486. PubMed ID: 38523225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.
    Follacchio GA; Monteleone F; Anibaldi P; De Vincentis G; Iacobelli S; Merola R; D'Orazi V; Monti M; Pasta V
    J Exp Clin Cancer Res; 2015 Oct; 34():113. PubMed ID: 26445493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients.
    van Hemert AKE; van Duijnhoven FH; Vrancken Peeters MTFD
    Breast; 2023 Oct; 71():89-95. PubMed ID: 37562108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.
    Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M
    Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.
    Simons JM; Scoggins ME; Kuerer HM; Krishnamurthy S; Yang WT; Sahin AA; Shen Y; Lin H; Bedrosian I; Mittendorf EA; Thompson A; Lane DL; Hunt KK; Caudle AS
    Ann Surg Oncol; 2021 Aug; 28(8):4277-4283. PubMed ID: 33417121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).
    Lim GH; Teo SY; Gudi M; Ng RP; Pang J; Tan YS; Lee YS; Allen JC; Leong LCH
    Cancer Med; 2020 Mar; 9(6):1978-1985. PubMed ID: 31970894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Aguayo-Albasini JL
    Cir Esp (Engl Ed); 2020 Nov; 98(9):510-515. PubMed ID: 32386728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
    Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT
    Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement.
    de Wild SR; Koppert LB; van Nijnatten TJA; Kooreman LFS; Vrancken Peeters MTFD; Smidt ML; Simons JM
    Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38531689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.
    Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI
    World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients.
    Acea-Nebril B; García-Novoa A; Bouzón Alejandro A; Díaz Carballada C; Conde Iglesias C
    Breast; 2023 Dec; 72():103592. PubMed ID: 37857128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study.
    Pulappadi VP; Paul S; Hari S; Dhamija E; Manchanda S; Kataria K; Mathur S; Mani K; Gogia A; Deo S
    Br J Radiol; 2021 Nov; 94(1127):20210788. PubMed ID: 34491822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results?
    Alarcón M; Buch E; Julve A; Hernandorena M; Tajahuerce M; Rodríguez H; Bermejo B; Ramírez J; Burgués O; Díaz S; Alcalá GM; Ortega J
    Surgeon; 2021 Dec; 19(6):344-350. PubMed ID: 33663946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection.
    Weinfurtner RJ; Leon A; Calvert A; Lee MC
    Clin Imaging; 2022 Oct; 90():19-25. PubMed ID: 35908456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
    Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients".
    Galimberti V; Ribeiro Fontana SK; Vicini E; Morigi C; Sargenti M; Corso G; Magnoni F; Intra M; Veronesi P
    Breast; 2023 Feb; 67():21-25. PubMed ID: 36566690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When the clipped node goes missing, CT guided SAVI SCOUT placement: A novel approach for localizing soft tissue targets.
    Lifrieri A; Fuzesi S; Desperito E; Taback B
    Clin Imaging; 2022 May; 85():115-117. PubMed ID: 35278870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).
    Brouwer OR; Vermeeren L; van der Ploeg IM; Valdés Olmos RA; Loo CE; Pereira-Bouda LM; Smit F; Neijenhuis P; Vrouenraets BC; Sivro-Prndelj F; Jap-a-Joe SM; Borgstein PJ; Rutgers EJ; Oldenburg HS
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1137-43. PubMed ID: 22526968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.